Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Filed with BSE · · 3 pages · English
Summary by 6ix AI
Asston Pharmaceuticals Limited has announced the appointment of new statutory auditors and the re-appointment of its Managing Director following shareholder approval. The company has also approved increases in remuneration for several directors.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Asston Pharmaceuticals Limited on 6ix
Earlier from Asston Pharmaceuticals
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Asston Pharmaceuticals Limited Press Release Sep 29 2026
- Asston Pharmaceuticals Limited Press Release Sep 27 2026
- Asston Pharmaceuticals Limited Press Release Sep 07 2026
- Asston Pharmaceuticals Limited Press Release Sep 05 2026
Later from Asston Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Change in Management
- Asston Pharmaceuticals Limited Press Release Oct 01 2026
- Board Meeting Intimation for To Consider And Approve The Following Matters As Attached
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Follow Asston Pharmaceuticals into a list and get an email when it puts out news.
Follow Asston Pharmaceuticals